Oral OTC switches
This article was originally published in The Rose Sheet
Executive Summary
Consumer Product Safety Commission is considering a staff proposal to require that all oral Rx-to-OTC switch drugs be packaged in child-resistant containers, CPSC Poison Prevention Project Manager Suzanne Barone, PhD, announces at a meeting in Bethesda, Md. June 7. Currently, the Poison Prevention Packaging Act calls for child-resistant packaging (CRP) for most oral Rx drugs, but not for products that switch to OTC unless it is specifically requested by the commission. CPSC already requires CRP for hair regrowth ingredient minoxidil (1"The Rose Sheet" Nov. 23, 1998, p. 8). The proposed rule would not cover other types of switches, such as topical preparations or transdermal patches